Related references
Note: Only part of the references are listed.Genomics, Biology, and Human Illness Advances in the Monogenic Autoinflammatory Diseases
Hirotsugu Oda et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2017)
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders
Hasan Hashem et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Screening of 181 Patients With Antibody Deficiency for Deficiency of Adenosine Deaminase 2 Sheds New Light on the Disease in Adulthood
Johanna Schepp et al.
ARTHRITIS & RHEUMATOLOGY (2017)
ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study
Roberta Caorsi et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation
Florence Fellmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency
Johanna Schepp et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2016)
Adenosine deaminase 2 deficiency presenting as spastic paraplegia and systemic vasculitis
Fabiano de Oliveira Poswar et al.
JOURNAL OF NEUROLOGY (2016)
Monogenic polyarteritis: the lesson of ADA2 deficiency
Roberta Caorsi et al.
PEDIATRIC RHEUMATOLOGY (2016)
Phenotypic variability in patients with ADA2 deficiency due to identical homozygous R169Q mutations
Joris M. Van Montfrans et al.
RHEUMATOLOGY (2016)
Deficiency of Adenosine Deaminase Type 2 A Description of Phenotype and Genotype in Fifteen Cases
Sira Nanthapisal et al.
ARTHRITIS & RHEUMATOLOGY (2016)
ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters
F. Uettwiller et al.
RMD OPEN (2016)
Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers
Silvia Federici et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency
Lien Van Eyck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations
Ezgi Deniz Batu et al.
JOURNAL OF RHEUMATOLOGY (2015)
Unexplained early-onset lacunar stroke and inflammatory skin lesions: Consider ADA2 deficiency
W. F. Westendorp et al.
NEUROLOGY (2015)
Dermatologic Features of ADA2 Deficiency in Cutaneous Polyarteritis Nodosa
Tania M. Gonzalez Santiago et al.
JAMA DERMATOLOGY (2015)
Early- Onset Stroke and Vasculopathy Associated with Mutations in ADA2
Qing Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy
Paulina Navon Elkan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mutations in CECR1 associated with a neutrophil signature in peripheral blood
Alexandre Belot et al.
PEDIATRIC RHEUMATOLOGY (2014)
Structural Basis for the Growth Factor Activity of Human Adenosine Deaminase ADA2
Anton V. Zavialov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells and macrophages
Andrey V. Zavialov et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity
AV Zavialov et al.
BIOCHEMICAL JOURNAL (2005)
Infevers: An evolving mutation database for auto-inflammatory syndromes
I Touitou et al.
HUMAN MUTATION (2004)